Does this mean GLP-1 medications could be prescribed to treat addiction in the future?

Possibly—but not yet. While early studies show promise for GLP-1s in reducing cravings for alcohol, nicotine, and opioids, the FDA has not approved any GLP-1 medications for addiction treatment. Researchers are still exploring how these drugs affect brain chemistry over time and whether their benefits can safely extend to substance use disorders.